InvestorsHub Logo
Followers 829
Posts 119621
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 482

Friday, 02/05/2021 12:56:10 PM

Friday, February 05, 2021 12:56:10 PM

Post# of 867
MRK—FDA briefing docs disparage KEYNOTE-522 study in adjuvant-TNBC:

https://endpts.com/fda-blasts-mercks-bid-for-adjuvant-keytruda-in-tnbc-before-adcomm-calling-late-stage-data-questionable/

As previously posted, this indication (adjuvant TNBC) could be highly material for MRK from a commercial standpoint—if the data are approvable.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News